Showing results (111-120 of 209) with videos related to
Sort By:
Pageof 21
Open Forum Infectious Diseases|May 19, 2016
Immunological Signaling During Herpes Simplex Virus-2 and Cytomegalovirus Vaginal Shedding After Initiation of Antiretroviral TreatmentMartha C Nason, Eshan U Patel, Allison R Kirkpatrick, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 3, 2024
Autoantibodies directed against interferon alpha, nuclear antigens, cardiolipin, and beta 2 glycoprotein 1 are not induced by SARS-CoV-2 or associated with long COVIDAdam Epstein-Shuman, Joanne H Hunt, Patrizio Caturegli, et al.Ebiomedicine|November 9, 2020
The association of α4β7 expression with HIV acquisition and disease progression in people who inject drugs and men who have sex with men: Case control studiesAlyssa R Martin, Eshan U Patel, Charles Kirby, et al.The Journal of Infectious Diseases|April 2, 2026
Pre-ART Vertical HIV-1 Transmission Risk in Uganda Varies by Sex of Child and Maternal Viral SubtypeZoe Gotthold, Adam Epstein-Shuman, Godfrey Kigozi, et al.Medrxiv : the Preprint Server for Health Sciences|February 16, 2022
Differential antibody production by symptomatology in SARS-CoV-2 convalescent individualsSharada Saraf, Xianming Zhu, Ruchee Shrestha, et al.The Journal of Infectious Diseases|November 30, 2017
Hepatitis E Virus Seroprevalence and Correlates of Anti-HEV IgG Antibodies in the Rakai District, UgandaDenali Boon, Andrew D Redd, Oliver Laeyendecker, et al.Journal of Clinical Microbiology|June 24, 2011
Identification of HIV superinfection in seroconcordant couples in Rakai, Uganda, by use of next-generation deep sequencingAndrew D Redd, Aleisha Collinson-Streng, Craig Martens, et al.Journal of Infection and Public Health|March 14, 2025
Autoantibodies to interferon alpha, nuclear antigens, cardiolipin, and beta 2 glycoprotein 1 in a Ugandan cohort and their relation to SARS-CoV-2 infectionAdam Epstein-Shuman, Xianming Zhu, Joanne H Hunt, et al.Nature Communications|August 24, 2023
SARS-CoV-2 vaccination elicits broad and potent antibody effector functions to variants of concern in vulnerable populationsAndrew P Hederman, Harini Natarajan, Leo Heyndrickx, et al.Transfusion|October 21, 2022
Absence of pathogenic viruses in COVID-19 convalescent plasmaAbraham J Kandathil, Sarah E Benner, Evan M Bloch, et al.Pageof 21